Companies researching Vaxzevria
Vaxzevria, previously known as the AstraZeneca COVID‑19 vaccine, is a pharmaceutical vaccine that reduces the risk of COVID‑19 infection in adults by using a modified adenovirus vector that carries the SARS‑CoV‑2 spike‑protein gene.
1
companies
List of companies that research Vaxzevria
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United Kingdom | Higher Education | 22k | $171M | Vaxzevria |
Showing top companies out of 1 that research Vaxzevria. Get the full list on TheirStack.
Frequently asked questions
